Beyond RAS and BRAF: HER2, a New Actionable Oncotarget in Advanced Colorectal Cancer

The human epidermal growth factor receptor 2 (HER2) is a well-established oncogenic driver and a successful therapeutic target in several malignancies, such as breast and gastric cancers. HER2 alterations, including amplification and somatic mutations, have also been detected in a small but not negl...

Descripción completa

Detalles Bibliográficos
Autores principales: Guarini, Chiara, Grassi, Teresa, Pezzicoli, Gaetano, Porta, Camillo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268006/
https://www.ncbi.nlm.nih.gov/pubmed/34202896
http://dx.doi.org/10.3390/ijms22136813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268006/
https://www.ncbi.nlm.nih.gov/pubmed/34202896
http://dx.doi.org/10.3390/ijms22136813

Ejemplares similares